139 related articles for article (PubMed ID: 9685888)
21. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride.
Snyman D; Hamman JH; Kotze AF
Drug Dev Ind Pharm; 2003 Jan; 29(1):61-9. PubMed ID: 12602493
[TBL] [Abstract][Full Text] [Related]
22. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.
Guggi D; Kast CE; Bernkop-Schnürch A
Pharm Res; 2003 Dec; 20(12):1989-94. PubMed ID: 14725364
[TBL] [Abstract][Full Text] [Related]
23. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system.
Langoth N; Kahlbacher H; Schöffmann G; Schmerold I; Schuh M; Franz S; Kurka P; Bernkop-Schnürch A
Pharm Res; 2006 Mar; 23(3):573-9. PubMed ID: 16411147
[TBL] [Abstract][Full Text] [Related]
24. Polymers with thiol groups: a new generation of mucoadhesive polymers?
Bernkop-Schnürch A; Schwarz V; Steininger S
Pharm Res; 1999 Jun; 16(6):876-81. PubMed ID: 10397608
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, Characterization and In Vitro Evaluation of a Novel Glycol Chitosan-EDTA Conjugate to Inhibit Aminopeptidase-Mediated Degradation of Thymopoietin Oligopeptides.
Feng J; Chen Y; Li F; Cui L; Shi N; Kong W; Zhang Y
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933740
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
[TBL] [Abstract][Full Text] [Related]
27. Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.
Bonferoni MC; Sandri G; Rossi S; Ferrari F; Gibin S; Caramella C
Eur J Pharm Sci; 2008 Feb; 33(2):166-76. PubMed ID: 18248966
[TBL] [Abstract][Full Text] [Related]
28. Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates.
Denora N; Lopedota A; Perrone M; Laquintana V; Iacobazzi RM; Milella A; Fanizza E; Depalo N; Cutrignelli A; Lopalco A; Franco M
Acta Biomater; 2016 Oct; 43():170-184. PubMed ID: 27427225
[TBL] [Abstract][Full Text] [Related]
29. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
30. Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
Bernkop-Schnürch A; Weithaler A; Albrecht K; Greimel A
Int J Pharm; 2006 Jul; 317(1):76-81. PubMed ID: 16595166
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
32. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
Bernkop-Schnürch A
J Control Release; 1998 Mar; 52(1-2):1-16. PubMed ID: 9685931
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin.
Song Y; Onishi H; Nagai T
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2822-5. PubMed ID: 1464115
[TBL] [Abstract][Full Text] [Related]
34. Chitosan: some pharmaceutical and biological aspects--an update.
Singla AK; Chawla M
J Pharm Pharmacol; 2001 Aug; 53(8):1047-67. PubMed ID: 11518015
[TBL] [Abstract][Full Text] [Related]
35. Chitosan-glycolic acid: a possible matrix for progesterone delivery into skin.
Kählig H; Hasanovic A; Biruss B; Höller S; Grim J; Valenta C
Drug Dev Ind Pharm; 2009 Aug; 35(8):997-1002. PubMed ID: 19365777
[TBL] [Abstract][Full Text] [Related]
36. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery.
Miyazaki S; Nakayama A; Oda M; Takada M; Attwood D
Biol Pharm Bull; 1994 May; 17(5):745-7. PubMed ID: 7920448
[TBL] [Abstract][Full Text] [Related]
37. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro evaluation of a novel thiolated chitosan.
Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
[TBL] [Abstract][Full Text] [Related]
39. Low molecular weight quaternised chitosan (I): synthesis and characterisation.
Snyman D; Govender T; Kotzé AF
Pharmazie; 2003 Oct; 58(10):705-8. PubMed ID: 14609281
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of pH tolerant and mucoadhesive (thiol-polyethylene glycol) chitosan graft polymer for drug delivery.
Hauptstein S; Bonengel S; Griessinger J; Bernkop-Schnürch A
J Pharm Sci; 2014 Feb; 103(2):594-601. PubMed ID: 24382680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
